Market Currents
Covidien (COV) lands FDA clearance to market its Covidien Nellcor respiration rate software. The...
-
Tuesday, March 20, 2012, 7:11 AM ETCovidien (COV) lands FDA clearance to market its Covidien Nellcor respiration rate software. The company plans a limited market release in U.S. hospitals starting next month.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles